Browse Title Index
Issue Title
Vol 3, Supp. A (2007) Renal cell carcinoma - patomorphology and genetic conditions Details   PDF (Polish)
Włodzimierz T. Olszewski
Vol 3, Supp. A (2007) Renal cell carcinoma treatment - introduction Details   PDF (Polish)
Piotr Siedlecki
Vol 7, No 3 (2011) Renal-cell carcinoma — current options for the second-line treatment with specific focus on the role of everolimus Abstract   PDF (Polish)
Piotr J. Wysocki, Jakub Żołnierek, Krzysztof Krzemieniecki, Kazimierz Drosik, Piotr Potemski, Maciej Krzakowski
Vol 19, No 3 (2023) Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement Abstract   PDF   HTML
Michał Gil, Izabela Chmielewska, Paweł Krawczyk, Przemysław Niziński, Maciej Strzemski, Janusz Milanowski
Vol 10, No 1 (2014) Report of Advanced Breast Cancer Second International Consensus Conference Abstract   PDF (Polish)
Katarzyna Pogoda, Renata Sienkiewicz-Kozłowska, Ewa Szombara
Vol 18, No 2 (2022) Resistance to neoadjuvant chemotherapy in breast cancer with proven intratumoral heterogeneity: a clinical case Abstract   PDF   HTML
Vasil D. Nanev, Silvia V. Naneva, Angel D. Yordanov, Strahil A. Strashilov, Ivan N. Ivanov
Vol 18, No 2 (2022) Response assessment in cancer immunotherapy. Cooperation between the oncologist and the radiologist Abstract   PDF   HTML
Jakub Pałucki, Jakub Kucharz
Vol 8, No 4 (2012) Response to third line hormonotherapy (fulvestrant) in patient with metastatic breast cancer after the f Abstract   PDF (Polish)
Katarzyna Gabalewicz, Marcin Ekiert, Emilia Filipczyk-Cisarż
Vol 17, No 6 (2021) Results of darbepoetin alfa treatment of anaemia in chemotherapy-receiving breast cancer patients: a single-centre retrospective observational study Abstract   PDF
Agnieszka Jagiełło-Gruszfeld, Anna Niwińska, Wojciech Michalski, Katarzyna Pogoda, Roman Dubiański, Michał Kunkiel, Izabela Lemańska, Renata Sienkiewicz, Anna Górniak, Ewa Kosakowska, Zbigniew Nowecki
Vol 15, No 6 (2019) Retrospective analysis of the efficacy and safety of cabazitaxel treatment in castration-resistant prostate cancer after docetaxel failure Abstract   PDF
Jakub Żołnierek, Wojciech Poborski, Wojciech Rogowski, Bogumiła Arłukowicz-Czartoryska, Karolina Skalska, Małgorzata Gola, Jakub Kucharz, Piotr J. Wysocki
Vol 16, No 2 (2020) Retrospective assessment of Lung-RADS® performance in the Silesian Lung Cancer Screening Pilot Study Abstract   PDF
Ewa Wachuła, Sylwia Szabłowska-Siwik, Damian Czyżewski, Jerzy Kozielski, Wojciech Rogowski, Mariusz Adamek
Vol 20, No 1 (2024) Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST) Abstract   PDF   HTML
Emilia Babula, Aleksandra Sikora, Paweł Sobczuk, Piotr Rutkowski
Vol 17, No 3 (2021) Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction Abstract   PDF
Paweł Krawczyk, Rodryg Ramlau, Justyna Błach, Robert Kieszko, Kazimierz Roszkowski-Ślisz, Tomasz Kucharczyk, Stanisław Kieszko, Janusz Milanowski
Vol 2, No 3 (2006) Rituximab in the treatment of follicular lymphoma Abstract   PDF (Polish)
Wojciech Jurczak, Jan Walewski
Vol 4, Supp. A (2008) Rola wysokodawkowanej chemioterapii w połączeniu z autologicznym przeszczepieniem macierzystych komórek krwiotwórczych w chłoniaku Hodgkina Abstract   PDF (Polish)
Jarosław Czyż
Vol 12, No 3 (2016) Role of immunohistochemical analysis in the diagnosis of gastric carcinosarcoma, a rare tumour — case report Abstract   PDF   HTML
Shafaq Maqsood
Vol 10, Supp. G (2014) Role of molecularly targeted therapy in the management of advanced non-small-cell lung cancer in the elderly Abstract   PDF (Polish)
Barbara Rybacka-Chabros
Vol 19, No 6 (2023) Role of TROP 2 overexpression in selected solid tumors Abstract   PDF   HTML
Agnieszka Chmielewska, Tomasz Kubiatowski
Vol 14, Supp. A (2018) Rozsiew czerniaka u 77-letniej chorej leczonej pierwotnie z powodu lentigo maligna Abstract   PDF (Polish)
Katarzyna Gabalewicz
Ahead of print Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers Abstract   PDF
Krzysztof Warzocha, Wojciech Homenda, Andrzej Pluta, Tomasz Sacha, Maria Cioch, Marek Dudziński, Dorota Krochmalczyk, Joanna Góra-Tybor, Ilona Seferyńska, Monika Joks, Marta Sobas
Vol 15, No 3 (2019) Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers Details   PDF
Krzysztof Warzocha, Wojciech Homenda, Andrzej Pluta, Tomasz Sacha, Maria Cioch, Marek Dudziński, Dorota Krochmalczyk, Joanna Góra-Tybor, Ilona Seferyńska, Monika Joks, Marta Sobas
Vol 19, No 1 (2023) Sacituzumab govitecan — a new therapy for patients with triple-negative breast cancer Abstract   PDF   HTML
Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Anna Niwińska, Zbigniew Nowecki
Vol 7, No 6 (2011) Sacral bone fracture — late side effect of radiotherapy. A case report Abstract   PDF (Polish)
Jakub Pałucki
Vol 7, No 6 (2011) Safety and efficacy of interferon-alfa2b (IFN) in the treatment of patients with mycosis fungoides Abstract   PDF (Polish)
Ewa Chmielowska, Aleksandra Grzanka, Anna Krause, Maciej Studziński, Marcin Świeżyński, Kinga Lewandowska, Katarzyna Kalinowska, Jan Kopeć
Vol 19, No 5 (2023) SARS-CoV-2 recurrent infections in a patient with metastatic colon cancer during chemotherapy Details   PDF   HTML
Filip Zieliński, Robert Wojciechowski, Joanna Terebińska, Anna Skrzypczyk-Ostaszewicz, Szymon Tomaszewski, Artur Maliborski, Katarzyna Sklinda, Hanna Cyngot, Wojciech Solarek, Magdalena Dobosz-Foligowska, Renata Duchnowska
876 - 900 of 1154 Items <<   <   31 32 33 34 35 36 37 38 39 40   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl